TUCSON, Ariz. (KGUN) — Diabetics have many options nowadays for their treatment plans. Afrezza is FDA-approved for adults with type 1 or type 2 diabetes as a fast-acting, mealtime insulin, but it ...

Cipla, a global name in inhalation therapies, has announced the launch of Afrezza, the world’s only rapid-acting inhaled insulin, in India. The drug is approved for adults with type 1 and type 2 ...

Trulicity (dulaglutide) is a brand-name injection prescribed to lower blood sugar levels and reduce the risk of certain cardiovascular problems. It works to treat these conditions by attaching to ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

New research shows how zinc, pH levels and insulin work together to inhibit the buildup of protein clumps that contribute to Type 2 diabetes. An estimated 462 million people around the world suffer ...

More than 500 million people worldwide suffer from diabetes. Roughly 2.6 billion are overweight. Something that both groups have in common is that the hormone insulinhormones does not work nearly as ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new approach that could reshape how this disease is managed. At the center of their ...

Type 2 diabetes is the most common type of diabetes. It occurs when your blood has high levels of sugar, also known as glucose. This can cause your pancreas, which is the organ that produces insulin, ...

Insulin resistance affects millions of people worldwide, yet many don’t realize their bodies are struggling to process blood sugar effectively until more serious health issues develop. This metabolic ...